Company / Free Cash Flow per Share
Caris Life Sciences, Inc. Free Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.83
FY2025
5-year range
-$8.54 / $1.83
FY2023-FY2025
Trend
+125.6%
vs FY2024
Sector context
#73 of 149
Health Care
What the data says
At $1.83, Caris Life Sciences, Inc.'s free cash flow per share ranks #73 of 149 in the Health Care sector. Improved from $-8.54 to $1.83 over the past 2 years.
Based on SEC 10-K filings.
1.83 in FY2025.
Improved from $-8.54 to $1.83 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 149 in Health CareTop 49% of 149This company $1.83 Sector average $5.00
▼
-63.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 125.6% year-over-year.
- Ranks #73 out of 149 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.83 | +125.6% |
| FY2024 | -$7.15 | +16.3% |
| FY2023 | -$8.54 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026